Skip to content

Drug interactions

Dipyridamole + Selexipag

Severity: Minor

Dipyridamole and Selexipag: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dipyridamole may inhibit BCRP, which transports selexipag. This could raise selexipag exposure and cause prostacyclin-type effects such as headache, flushing, jaw pain, diarrhea and hypotension. The interaction is predicted from transporter data.

What this interaction means in plain words

Dipyridamole and Selexipag have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dipyridamole belongs to Cardiovascular; Selexipag belongs to Cardiovascular.

Evidence level: Low

Why it happens

BCRP inhibition by dipyridamole may increase selexipag systemic exposure.

What to do

Monitor for selexipag adverse effects such as headache, hypotension and diarrhea, and adjust the selexipag dose if tolerability is poor.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dipyridamole and Selexipag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dipyridamole with Selexipag?

MediHelp rates the interaction as minor. Dipyridamole and Selexipag have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dipyridamole may inhibit BCRP, which transports selexipag. This could raise selexipag exposure and cause prostacyclin-type effects such as headache, flushing, jaw pain, diarrhea and hypotension. The interaction is predicted from transporter data.

How serious is the interaction between Dipyridamole and Selexipag?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for selexipag adverse effects such as headache, hypotension and diarrhea, and adjust the selexipag dose if tolerability is poor.

What other medicines interact with Dipyridamole?

MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in